UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate
by Jeong Sae-im
2020-04-28 14:48
Researchers start testing pancreatitis drug to fight Covid-19
by Kim Yun-mi
2020-04-28 11:22
Genexine to present test results at US cancer academy
by Shim Hyun-tai
2020-04-27 16:14
‘Parasiticide showed antiviral effect as potential Covid-19 drug’
by Jeong Sae-im
2020-04-24 12:27
French envoy visits Pasteur Korea to watch Covid-19 research
by Jeong Sae-im
2020-04-23 17:13
라인
Multinational drugmakers donated ₩30 billion last year
by Kim Yun-mi
2020-04-23 15:09
4 drugs recorded two-digit sales growth in Q1 despite Covid-19
by Jeong Sae-im
2020-04-23 12:18
Medytox’s faking data unpunishable due to expired statute of limitations
by Jeong Sae-im
2020-04-22 11:28
Abclon derives clinical materials for CAR-T treatment of ovarian cancer
by Shim Hyun-tai
2020-04-21 17:49
Multidisciplinary cure is mainstream cancer treatment but cumbersome
by Park Gi-taek
2020-04-21 17:09
라인
Whistleblowers, shareholders furious over Medytox’s rebuttal
by Jeong Sae-im
2020-04-21 15:19
ImmuneMed confident of drug candidate’s effect on Covid-19
by Jeong Sae-im
2020-04-21 13:23
Medytox files suit to cancel administrative order
by Shim Hyun-tai
2020-04-20 16:37
DM Bio signs CDMO contract with Abion for antibody treatment
by Shim Hyun-tai
2020-04-17 16:03
Medytox CEO charged with making, selling botulinum toxin illegally
by Jeong Sae-im
2020-04-17 16:00
라인
Researchers to test asthma drug to treat Covid-19
by Kim Yun-mi
2020-04-16 16:20
Bukwang to test its antiviral drug against Covid-19
by Jeong Sae-im
2020-04-16 12:20
Opdivo’s indication expanded to esophageal squamous cell carcinoma
by Kim Yun-mi
2020-04-16 10:48
Pasteur, Daewoong to co-develop COVID-19 drug from parasiticide
by Shim Hyun-tai
2020-04-14 17:49
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why?
by Kim Yun-mi
2020-04-10 15:36
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top